StockData
Oculis Holding AG logo

Oculis Holding AG (OCS) stock

OCSNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as OCSAW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 4, 2026Score 1/30
$7.39−0.12 (-1.60%)

Close on Nov 18, 2026Market cap $444.06MP/E –Yield –

Oculis shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Oculis's shares outstanding was 61M at Jun 30, 2026. For fiscal 2025 it was 52M, up 29.3% from the year before. The highest annual figure on record is 52M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 202552M+29.3%
FY2024Dec 31, 202440M+35.1%
FY2023Dec 31, 202330M+900.2%
FY2022Dec 31, 20223M+7.6%
FY2021Dec 31, 20213M+7.7%
FY2020Dec 31, 20203M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 202661M–
Q2 FY2025Jun 30, 202552M–
Q2 FY2024Jun 30, 202441M–
Q2 FY2023Jun 30, 202334M–

More Oculis figures

See a number that looks wrong?